Study Long COVID symptoms in the Canary Islands
Part of Infections, Lungs & breathing clinical trials.
This study looks at how common long-term COVID symptoms are in people across the Canary Islands. It may help researchers better understand who is affected and what symptoms last, which can support future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You tested positive for COVID-19 on or after March 14, 2020 (start of the Spanish COVID alert period).
- You still have COVID-related symptoms at least 12 weeks after you first detected COVID.
- You can understand and complete study tests (enough mentally and physically).
- You can participate with informed consent (you sign the consent form).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how your immune system responds in people with Long COVID after a past COVID-19 infection. It may help researchers understand why symptoms linger and how the body’s response could be targeted.
This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This study follows people who were hospitalized for COVID-19 to learn more about long-term health effects (post-COVID conditions). It uses blood samples already collected during their hospital stay.
This study looks at why some people develop long-term lung problems after COVID-19. It compares people who had severe COVID-19 and were hospitalized to those who had mild infections and recovered at home.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.